secwatch.observer — SEC 8-K summary
======================================

Issuer:     LABCORP HOLDINGS INC. (LH)
CIK:        0000920148
Form:       8-K/A
Filed at:   2023-05-05T23:59:59+00:00
Accession:  0000920148-23-000036
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Labcorp corrects transposed equity award values for Caveney appointment; salary $650K
--------------------------------------------------------------------------------

- Corrected RSU and stock option awards each valued at $67,000 (were transposed).
- Corrected performance share award value of $201,000.
- Base salary increased to $650,000 effective May 1, 2023.
- Caveney appointed EVP, President Early Development & Chief Medical and Scientific Officer.
- Role part of internal restructuring for planned spin-off of clinical development business.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/920148/000092014823000036/0000920148-23-000036-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/920148/000092014823000036/lh-20230501.htm
  HTML page:      https://secwatch.observer/filing/0000920148-23-000036

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer